Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Bharat Parenterals Ltd
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 50.97 | 69.91 | 59.81 | 59.82 | 67.82 | 92.51 | 71.63 | 72.26 | 103.98 | 116.00 | 64.62 | 65.19 | 99.62 |
| Expenses + | 44.75 | 59.46 | 55.49 | 53.21 | 66.82 | 88.02 | 79.29 | 68.62 | 101.75 | 102.22 | 63.79 | 63.45 | 100.14 |
| Operating Profit | 6.22 | 10.45 | 4.32 | 6.61 | 1.00 | 4.49 | -7.66 | 3.64 | 2.23 | 13.78 | 0.83 | 1.74 | -0.52 |
| OPM % | 12.20% | 14.95% | 7.22% | 11.05% | 1.47% | 4.85% | -10.69% | 5.04% | 2.14% | 11.88% | 1.28% | 2.67% | -0.52% |
| Other Income + | 0.31 | 2.10 | 2.60 | 1.26 | 2.64 | 2.54 | 4.21 | 2.94 | 1.93 | 1.06 | 3.53 | 1.33 | 3.63 |
| Interest | 0.80 | 0.89 | 0.63 | 0.58 | 1.13 | 2.77 | 2.91 | 3.33 | 3.94 | 3.69 | 3.11 | 2.90 | 2.85 |
| Depreciation | 1.44 | 1.58 | 1.75 | 1.82 | 3.87 | 9.03 | 9.01 | 8.76 | 8.52 | 8.60 | 8.56 | 8.46 | 8.63 |
| Profit before tax | 4.29 | 10.08 | 4.54 | 5.47 | -1.36 | -4.77 | -15.37 | -5.51 | -8.30 | 2.55 | -7.31 | -8.29 | -8.37 |
| Tax % | 47.09% | 30.46% | 46.48% | 33.46% | 88.24% | 85.32% | 13.92% | 43.01% | 13.61% | 134.12% | 17.65% | 16.77% | -2.51% |
| Net Profit + | 2.27 | 7.01 | 2.43 | 3.64 | -2.56 | -8.84 | -17.51 | -7.88 | -9.44 | -0.87 | -8.60 | -9.67 | -8.16 |
| EPS in Rs | 4.31 | 13.02 | 6.05 | 6.50 | -0.52 | 1.96 | -11.50 | -2.42 | -6.86 | 11.94 | -10.49 | -6.37 | -6.96 |
Financials of Bharat Parenterals Ltd
Annual income statement trend
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 124 | 111 | 137 | 220 | 228 | 205 | 212 | 218 | 261 | 340 | 345 |
| Expenses + | 114 | 105 | 124 | 191 | 200 | 179 | 183 | 198 | 234 | 337 | 330 |
| Operating Profit | 10 | 7 | 12 | 29 | 28 | 25 | 29 | 20 | 27 | 4 | 16 |
| OPM % | 8% | 6% | 9% | 13% | 12% | 12% | 14% | 9% | 10% | 1% | 5% |
| Other Income + | 5 | 8 | 7 | 13 | 11 | 9 | 7 | 12 | 5 | 11 | 10 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 13 | 13 |
| Depreciation | 4 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 9 | 35 | 34 |
| Profit before tax | 9 | 7 | 13 | 35 | 33 | 27 | 28 | 24 | 19 | -34 | -21 |
| Tax % | 31% | 8% | 29% | 39% | 26% | 25% | 25% | 33% | 44% | 29% | 27% |
| Net Profit + | 6 | 7 | 9 | 21 | 24 | 20 | 21 | 16 | 11 | -44 | -27 |
| EPS in Rs | 11.26 | 12.03 | 15.92 | 37.09 | 42.13 | 35.59 | 36.45 | 28.47 | 24.95 | -18.33 | -11.88 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 3% | 4% | -5% | -8% |
Financials of Bharat Parenterals Ltd
Capital structure and asset base
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
| Reserves | 51 | 58 | 67 | 88 | 112 | 138 | 160 | 177 | 191 | 324 | 315 |
| Borrowings + | 19 | 6 | 9 | 5 | 1 | 12 | 18 | 50 | 158 | 180 | 146 |
| Other Liabilities + | 44 | 40 | 50 | 60 | 68 | 43 | 42 | 118 | 149 | 138 | 145 |
| Total Liabilities | 120 | 110 | 132 | 159 | 188 | 199 | 226 | 350 | 504 | 649 | 613 |
| Fixed Assets + | 35 | 31 | 34 | 35 | 33 | 45 | 41 | 42 | 211 | 252 | 256 |
| CWIP | 0 | 0 | 0 | 1 | 12 | 0 | 26 | 99 | 25 | 31 | 34 |
| Investments | 0 | 1 | 1 | 1 | 0 | 43 | 11 | 0 | 0 | 5 | 6 |
| Other Assets + | 85 | 79 | 98 | 121 | 142 | 111 | 148 | 209 | 268 | 360 | 317 |
| Total Assets | 120 | 110 | 132 | 159 | 188 | 199 | 226 | 350 | 504 | 649 | 613 |
Financials of Bharat Parenterals Ltd
Operating, investing and financing cash movement
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 0 | -2 | 6 | 20 | 14 | 24 | -1 | 22 | -5 | -27 | 38 |
| Cash from Investing Activity + | 0 | -2 | -8 | -9 | -13 | -43 | -7 | -78 | -105 | -137 | 9 |
| Cash from Financing Activity + | 0 | -8 | 4 | -4 | -3 | 10 | 9 | 61 | 110 | 156 | -47 |
| Net Cash Flow | 0 | -11 | 2 | 7 | -1 | -8 | 2 | 4 | 1 | -8 | 1 |
| Free Cash Flow | 0 | -4 | -2 | 12 | -0 | 24 | -40 | -68 | -108 | -56 | -1 |
| CFO/OP | 0% | -8% | 73% | 107% | 87% | 123% | 16% | 150% | 18% | -444% | 305% |
Financials of Bharat Parenterals Ltd
Working capital efficiency and return ratios
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 130 | 143 | 157 | 106 | 127 | 121 | 126 | 188 | 198 | 184 | 159 |
| Inventory Days | 62 | 70 | 60 | 59 | 71 | 61 | 56 | 100 | 142 | 142 | 162 |
| Days Payable | 171 | 168 | 110 | 83 | 104 | 71 | 64 | 136 | 137 | 146 | 122 |
| Cash Conversion Cycle | 21 | 45 | 107 | 82 | 93 | 111 | 118 | 152 | 202 | 180 | 199 |
| Working Capital Days | 8 | 64 | 78 | 73 | 89 | 106 | 148 | 91 | 81 | 79 | 149 |
| ROCE % | 11% | 18% | 39% | 31% | 20% | 17% | 11% | 7% | -4% | -2% |